Community risks for SARS-CoV-2 infection among fully vaccinated US adults by rurality : A retrospective cohort study from the National COVID Cohort Collaborative

Copyright: © 2023 Anzalone et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited..

BACKGROUND: While COVID-19 vaccines reduce adverse outcomes, post-vaccination SARS-CoV-2 infection remains problematic. We sought to identify community factors impacting risk for breakthrough infections (BTI) among fully vaccinated persons by rurality.

METHODS: We conducted a retrospective cohort study of US adults sampled between January 1 and December 20, 2021, from the National COVID Cohort Collaborative (N3C). Using Kaplan-Meier and Cox-Proportional Hazards models adjusted for demographic differences and comorbid conditions, we assessed impact of rurality, county vaccine hesitancy, and county vaccination rates on risk of BTI over 180 days following two mRNA COVID-19 vaccinations between January 1 and September 21, 2021. Additionally, Cox Proportional Hazards models assessed the risk of infection among adults without documented vaccinations. We secondarily assessed the odds of hospitalization and adverse COVID-19 events based on vaccination status using multivariable logistic regression during the study period.

RESULTS: Our study population included 566,128 vaccinated and 1,724,546 adults without documented vaccination. Among vaccinated persons, rurality was associated with an increased risk of BTI (adjusted hazard ratio [aHR] 1.53, 95% confidence interval [CI] 1.42-1.64, for urban-adjacent rural and 1.65, 1.42-1.91, for nonurban-adjacent rural) compared to urban dwellers. Compared to low vaccine-hesitant counties, higher risks of BTI were associated with medium (1.07, 1.02-1.12) and high (1.33, 1.23-1.43) vaccine-hesitant counties. Compared to counties with high vaccination rates, a higher risk of BTI was associated with dwelling in counties with low vaccination rates (1.34, 1.27-1.43) but not medium vaccination rates (1.00, 0.95-1.07). Community factors were also associated with higher odds of SARS-CoV-2 infection among persons without a documented vaccination. Vaccinated persons with SARS-CoV-2 infection during the study period had significantly lower odds of hospitalization and adverse events across all geographic areas and community exposures.

CONCLUSIONS: Our findings suggest that community factors are associated with an increased risk of BTI, particularly in rural areas and counties with high vaccine hesitancy. Communities, such as those in rural and disproportionately vaccine hesitant areas, and certain groups at high risk for adverse breakthrough events, including immunosuppressed/compromised persons, should continue to receive public health focus, targeted interventions, and consistent guidance to help manage community spread as vaccination protection wanes.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:18

Enthalten in:

PloS one - 18(2023), 1 vom: 15., Seite e0279968

Sprache:

Englisch

Beteiligte Personen:

Anzalone, Alfred Jerrod [VerfasserIn]
Sun, Jing [VerfasserIn]
Vinson, Amanda J [VerfasserIn]
Beasley, William H [VerfasserIn]
Hillegass, William B [VerfasserIn]
Murray, Kimberly [VerfasserIn]
Hendricks, Brian M [VerfasserIn]
Haendel, Melissa [VerfasserIn]
Geary, Carol Reynolds [VerfasserIn]
Bailey, Kristina L [VerfasserIn]
Hanson, Corrine K [VerfasserIn]
Miele, Lucio [VerfasserIn]
Horswell, Ronald [VerfasserIn]
McMurry, Julie A [VerfasserIn]
Porterfield, J Zachary [VerfasserIn]
Vest, Michael T [VerfasserIn]
Bunnell, H Timothy [VerfasserIn]
Harper, Jeremy R [VerfasserIn]
Price, Bradley S [VerfasserIn]
Santangelo, Susan L [VerfasserIn]
Rosen, Clifford J [VerfasserIn]
McClay, James C [VerfasserIn]
Hodder, Sally L [VerfasserIn]
National COVID Cohort Collaborative (N3C) Consortium [VerfasserIn]

Links:

Volltext

Themen:

COVID-19 Vaccines
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.

Anmerkungen:

Date Completed 09.01.2023

Date Revised 25.10.2023

published: Electronic-eCollection

Citation Status MEDLINE

doi:

10.1371/journal.pone.0279968

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM351141774